Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Hematología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).
INTERVENTIONAL
Inicio: 28 de feb de 2013
ID: NCT01776424
Completado
Fase 3
ClinicalTrials.gov
Recombinant Factor IX (BAX 326): A Phase 1/3, Prospective, Controlled, Multicenter Study Evaluating Pharmacokinetics, Efficacy, Safety and Immunogenicity in Previously Treated Patients With Severe or Moderately Severe Hemophilia B
INTERVENTIONAL
Inicio: 29 de jul de 2010
ID: NCT01174446
Completado
Fase 3
ClinicalTrials.gov
Randomized, Controlled, Parallel, Prospective Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects, as Applicable, Compared to That of Episodic Treatment
INTERVENTIONAL
Inicio: 1 de mar de 2008
ID: NCT00623480
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Multicenter, Phase 3 Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy
INTERVENTIONAL
Inicio: 2 de mar de 2006
ID: NCT00338286
Activo, no recluta
Fase 4
ClinicalTrials.gov
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
INTERVENTIONAL
Inicio: 20 de sept de 2019
ID: NCT03950076
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
INTERVENTIONAL
Inicio: 30 de jun de 2015
ID: NCT02467270
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Oral Rilzabrutinib (PRN1008) in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)
INTERVENTIONAL
Inicio: 14 de dic de 2020
ID: NCT04562766
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Open-Label, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein (rFVIIIFc-VWF-XTEN; BIVV001) in Previously Treated Patients ≥12 Years of Age With Severe Hemophilia A
INTERVENTIONAL
Inicio: 19 de nov de 2019
ID: NCT04161495
Activo, no recluta
Fase 3
ClinicalTrials.gov
PROCLAIM: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy-induced Thrombocytopenia in Patients Receiving Chemotherapy for Treatment of Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
INTERVENTIONAL
Inicio: 26 de feb de 2020
ID: NCT03937154
Completado
Fase 3
ClinicalTrials.gov
Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (INNO2VATE-CONVERSION)
INTERVENTIONAL
Inicio: 1 de ago de 2016
ID: NCT02892149
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure
INTERVENTIONAL
Inicio: 1 de nov de 2013
ID: NCT01976104
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of Edoxaban (DU-176b) Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE - AF TIMI - 48)
INTERVENTIONAL
Inicio: 1 de nov de 2008
ID: NCT00781391
Completado
Fase 3
ClinicalTrials.gov
A Single-Arm Open-Label Study to Assess the Efficacy, Safety, and Tolerability of Once-Monthly Administration of Intravenous and/or Subcutaneous C.E.R.A for the Maintenance of Hemoglobin Levels in Dialysis Patients With Chronic Renal Anemia
INTERVENTIONAL
Inicio: 1 de oct de 2007
ID: NCT00517413
Completado
Fase 3
ClinicalTrials.gov
Randomized, Multinational, Double-blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Myocardial Infarction Managed With an Early Invasive Strategy.
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00335452
Completado
Fase 3
ClinicalTrials.gov
RECITE: A Phase 3 Randomized Placebo-controlled Double-blind Study of Romiplostim for the Treatment of Chemotherapy- Induced Thrombocytopenia in Patients Receiving Oxaliplatin-based Chemotherapy for Treatment of Gastrointestinal, Pancreatic, or Colorectal Cancer
INTERVENTIONAL
Inicio: 30 de sept de 2019
ID: NCT03362177
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)
INTERVENTIONAL
Inicio: 22 de jul de 2022
ID: NCT05254743
Completado
Fase 3
ClinicalTrials.gov
BAX 326 (Recombinant Factor IX): Evaluation of Safety, Immunogenicity, and Hemostatic Efficacy in Previously Treated Patients With Severe (FIX Level < 1%) or Moderately Severe (FIX Level <= 2%) Hemophilia B - A Continuation Study
INTERVENTIONAL
Inicio: 12 de abr de 2011
ID: NCT01286779
Reclutando
Fase 2
ClinicalTrials.gov
Efectividad Del Plasma Rico en Plaquetas (PRP) Para la disminución Objetiva Del Dolor y la recuperación Funcional Del Miembro Inferior en Osteoartritis de Rodilla. Evaluación de Alternativas metodológicas
INTERVENTIONAL
Inicio: 1 de may de 2024
ID: NCT05825105
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Period and Long-term Extension to Assess the Efficacy and Safety of Rilzabrutinib in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
INTERVENTIONAL
Inicio: 18 de ago de 2025
ID: NCT07086976
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00358215
Anterior
1
...
8
9
10
...
434
Siguiente
Filtros